MoneyWorks4Me

Strides Pharma Scien - Quaterly Results

22 May 2024 Evaluate
A fair growth of 9.60% in the revenue at Rs. 6176.32 millions was reported in the March 2024 quarter as compared to Rs. 5635.57 millions during year-ago period.The Company's Net profit for the March 2024 quarter have declined marginally to Rs. 536.64  millions as against Rs. 623.97 millions reported during the corresponding quarter ended.A decline of 1204.25 millions was observed in the OP in the quarter ended March 2024 from 1458.13 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 6176.32 5635.57 9.60 21532.58 18544.96 16.11 21532.58 18544.96 16.11
Other Income 296.34 263.78 12.34 723.06 840.66 -13.99 723.06 840.66 -13.99
PBIDT 1204.25 1458.13 -17.41 3275.82 1825.43 79.45 3275.82 1825.43 79.45
Interest 467.66 429.01 9.01 1679.28 1386.82 21.09 1679.28 1386.82 21.09
PBDT 735.85 879.12 -16.30 1542.89 288.61 434.59 1542.89 288.61 434.59
Depreciation 208.07 227.12 -8.39 846.68 936.21 -9.56 846.68 936.21 -9.56
PBT 527.78 652.00 -19.05 696.21 -647.60 -207.51 696.21 -647.60 -207.51
TAX -8.86 28.03 -131.61 41.30 -694.42 -105.95 41.30 -694.42 -105.95
Deferred Tax 19.42 258.12 -92.48 38.18 -195.99 -119.48 38.18 -195.99 -119.48
PAT 536.64 623.97 -14.00 654.91 46.82 1298.78 654.91 46.82 1298.78
Equity 919.00 903.03 1.77 919.00 903.03 1.77 919.00 903.03 1.77
PBIDTM(%) 19.50 25.87 -24.64 15.21 9.84 54.55 15.21 9.84 54.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..